Valuation: DEEPVERGE

Market Cap 8.75M 7.94M 7.33M 6.62M 12.49M 817M 12.97M 88.37M 34.95M 441M 32.81M 32.12M 1.39B P/E 2020
-12.5x
P/E 2021 -19.3x
Enterprise Value 9.18M 8.33M 7.7M 6.94M 13.11M 858M 13.61M 92.75M 36.69M 463M 34.44M 33.71M 1.46B EV / Sales 2020
10x
EV / Sales 2021 6.11x
Free-Float
90.54%
Yield 2020 *
-
Yield 2021 -
5 years 0
Extreme 0.0005
0.31
10 years 0
Extreme 0.0005
0.42
Manager TitleAgeSince
Chief Executive Officer 68 01/11/2022
Director of Finance/CFO - 30/08/2018
Sales & Marketing 53 12/07/2021
Director TitleAgeSince
Chairman 66 21/05/2019
Director/Board Member 68 10/11/2020
Date Insider Type Main position Quantity % Market Cap. Importance
16/11/22 Free

Executive/Senior Manager

162,500 0.0740%
16/11/22 Buy

Chief Financial Officer

2,000,000 0.9103%
16/11/22 Buy

Executive/Senior Manager

650,000 0.2958%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-.--% 421K
-2.27%-1.47%+27.94%+67.00% 786B
-0.87%-1.37%+20.92%+62.20% 88.23B
-1.11%-2.03%+34.21%+125.07% 67.03B
-4.40%-7.33%+34.67%+36.29% 47.94B
-1.22%-1.14%-6.11%+2.78% 48.27B
-1.60%-1.60%-0.62%-49.78% 33.15B
-0.07%-0.86%+30.32%+20.17% 33.04B
-1.02%-20.87%+23.33%+459.85% 31.07B
-2.04%-1.59%+64.97%+94.28% 28.94B
Average -0.19%-3.89%+22.96%+81.79% 116B
Weighted average by Cap. -1.61%-2.19%+26.69%+72.56%

Financials

2020 2021
Net sales 4.48M 4.07M 3.76M 3.39M 6.4M 419M 6.65M 45.3M 17.92M 226M 16.82M 16.47M 714M 9.3M 8.44M 7.8M 7.03M 13.28M 869M 13.79M 93.94M 37.16M 469M 34.88M 34.15M 1.48B
Net income -2.72M -2.47M -2.28M -2.06M -3.88M -254M -4.03M -27.46M -10.86M -137M -10.2M -9.98M -433M -2.68M -2.43M -2.25M -2.03M -3.83M -250M -3.97M -27.07M -10.71M -135M -10.05M -9.84M -427M
Net Debt 1.11M 1.01M 933K 842K 1.59M 104M 1.65M 11.25M 4.45M 56.11M 4.18M 4.09M 177M 434K 394K 364K 328K 620K 40.55M 644K 4.39M 1.73M 21.88M 1.63M 1.59M 69.13M
Logo DEEPVERGE
Deepverge PLC is an Ireland-based vertically integrated company. The Company provides core skin and human testing technology. The Company is engaged in collaborating technology platforms with partners in artificial intelligence (AI), clinical research, medical device, life science and environmental science. Its Labskin delivers human skin microbiology services to support product R&D activities in the cosmetic, personal care, medical device and pharmaceutical sectors. The Labskin model is a 3D human skin equivalent that incorporates vital biological components to model normal skin function. It allows skin-care, health-care, nutritional, pharmaceutical manufacturers and cosmetic companies to test consumer products on human-like skin in a real-world environment with full access to multiple partner technologies.
Employees
73